SEP 24, 2019 7:00 PM PDT

Promising Drug for Prostate Cancer

WRITTEN BY: Nouran Amin

Using high-throughput screening methods, cancer researchers from the UK have identified some promising drug candidates to test thousands of molecules. Specifically, they studied a protein called-methylacyl-CoA racemase (AMACR) as a potential target for therapeutics in prostate cancers. The experiments show that reducing the AMACR protein makes cancer cells less aggressive and allows their behavior to be like normal cells.

“The protein AMACR has been shown to be present in larger quantities in aggressive prostate cancer cells, and this research group have successfully developed a technique to find the protein and monitor its activity. Further to this, they have now found certain compounds that can target this protein's activity in the lab, and stop the cancer cells in their tracks,” says Simon Grieveson, Head of Research Funding at Prostate Cancer UK.

The study examined more than 20,000 drug-like molecules that inhibit the activity of AMACR using a method known as simple color-change technique. The technique allows for quick assessment of active compounds and identification of new types of drugs. Findings were published in the journal Bioorganic Chemistry.

Lead author Dr Matthew Lloyd said: "Although previously identified drugs are very effective in laboratory tests, in practice they are difficult to use in therapies because their properties do not allow easy distribution throughout the body. We started this study because we wanted to identify drugs which would be easier to use therapeutically. Although the particular compounds identified in this study did not kill prostate cancer cells very effectively, it is very promising that drug-like molecules were identified,” says lead author of the study, Dr. Matthew Lloyd rom the University of Bath.

Learn more about prostate cancer:

“The research is still in its infancy and is some way off from clinical investigation, however this is certainly promising and we look forward to seeing how this research progresses over the coming years,” says Grieveson.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
SEP 24, 2021
Drug Discovery & Development
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
SEP 24, 2021
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
The World Health Organization (WHO) has recommended a combination of two antibody treatments for patients at risk of adv ...
OCT 25, 2021
Health & Medicine
Latest Cannabis Extraction Developments
OCT 25, 2021
Latest Cannabis Extraction Developments
In response to the growing demand for concentrates, cannabis product manufacturers are exploring new technological advan ...
OCT 29, 2021
Drug Discovery & Development
A novel analogue of psilocin to treat mental health disorders
OCT 29, 2021
A novel analogue of psilocin to treat mental health disorders
Psilocybin and its metabolite psilocin are naturally occurring compounds that are commonly found in some genus of mushro ...
NOV 22, 2021
Cancer
A New Treatment Option for Patients with Cancer in the Eye
NOV 22, 2021
A New Treatment Option for Patients with Cancer in the Eye
Uveal melanoma (UM) is a rare malignancy characterized by the formation of cancer cells in the tissues of the eye. UM be ...
NOV 10, 2021
Drug Discovery & Development
Inflammation during pregnancy can affect normal brain development
NOV 10, 2021
Inflammation during pregnancy can affect normal brain development
During pregnancy the growing embryo and fetus undergo remarkable and quick developmental. Around 5 weeks after ...
NOV 30, 2021
Cannabis Sciences
To Trust or Not to Trust the Process: Bioreactive Chemical Variation in Cannabis Extracts Based on Extraction Method
NOV 30, 2021
To Trust or Not to Trust the Process: Bioreactive Chemical Variation in Cannabis Extracts Based on Extraction Method
With cannabis legislation becoming increasingly less restrictive over the past 20 years, consumers have found themselves ...
Loading Comments...